Skip to main content
Erschienen in: Quality of Life Research 9/2012

01.11.2012

Measuring quality of life in rural Uganda: reliability and validity of summary scores from the Medical Outcomes Study HIV Health Survey (MOS-HIV)

verfasst von: Anne L. Stangl, Rebecca Bunnell, Nafuna Wamai, Humphrey Masaba, Jonathan Mermin

Erschienen in: Quality of Life Research | Ausgabe 9/2012

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Purpose

Summary scores derived from the Medical Outcomes Study HIV Health Survey (MOS-HIV) are used to assess treatment impacts among HIV-infected patients in Western settings, but have yet to be validated in rural, African settings. We examined the reliability, validity and responsiveness of scores among a prospective cohort of 947 HIV-1-infected adults initiating antiretroviral therapy between May 2003 and May 2004 in rural Uganda.

Methods

Physical (PHS) and mental health (MHS) summary scores were developed from baseline MOS-HIV sub-domains using exploratory factor analysis. Construct and discriminant validity were established by comparing mean summary scores across known groups of sociodemographic, clinical and health status characteristics. Effect sizes were calculated to assess responsiveness to therapy.

Results

Reliability of the PHS and MHS scores was 0.79 and 0.85, respectively. Mean baseline PHS and MHS scores varied significantly by CD4 cell count, HIV viral load, WHO stage of disease and Karnofsky performance status scores. By 12 months on antiretroviral therapy, PHS and MHS scores improved by 14.6 points (P < 0.001) and 13.9 points (P < 0.001), respectively.

Conclusions

PHS and MHS scores can be derived from the MOS-HIV and used to assess health status among cohorts of patients taking antiretroviral therapy in rural Uganda.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literatur
1.
Zurück zum Zitat UNAIDS, World Health Organization. (2005). Progress on global access to HIV antiretroviral therapy: An update on “3 by 5”. In Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS) (pp. 1–55). World Health Organization (WHO). UNAIDS, World Health Organization. (2005). Progress on global access to HIV antiretroviral therapy: An update on “3 by 5”. In Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS) (pp. 1–55). World Health Organization (WHO).
2.
Zurück zum Zitat Wu, A. W. (2000). Quality of life assessment comes of age in the era of highly active antiretroviral therapy. AIDS, 14(10), 1449–1451.PubMedCrossRef Wu, A. W. (2000). Quality of life assessment comes of age in the era of highly active antiretroviral therapy. AIDS, 14(10), 1449–1451.PubMedCrossRef
3.
Zurück zum Zitat Wu, A. W., Revicki, D. A., Jacobson, D., & Malitz, F. E. (1997). Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Quality of Life Research, 6(6), 481–493.PubMedCrossRef Wu, A. W., Revicki, D. A., Jacobson, D., & Malitz, F. E. (1997). Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Quality of Life Research, 6(6), 481–493.PubMedCrossRef
4.
Zurück zum Zitat Revicki, D. A., Sorensen, S., & Wu, A. W. (1998). Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Medical Care, 36(2), 126–137.PubMedCrossRef Revicki, D. A., Sorensen, S., & Wu, A. W. (1998). Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Medical Care, 36(2), 126–137.PubMedCrossRef
5.
Zurück zum Zitat Holmes, W., Bix, B., & Shea, J. (1996). SF-20 score and item distributions in a human immunodeficiency virus-seropositive sample. Medical Care, 34(6), 562–569.PubMedCrossRef Holmes, W., Bix, B., & Shea, J. (1996). SF-20 score and item distributions in a human immunodeficiency virus-seropositive sample. Medical Care, 34(6), 562–569.PubMedCrossRef
6.
Zurück zum Zitat World Health Organization. (2002). Scaling up antiretroviral therapy in resource limited settings: Guidelines for a Public Health Approach. Geneva: World Health Organization. World Health Organization. (2002). Scaling up antiretroviral therapy in resource limited settings: Guidelines for a Public Health Approach. Geneva: World Health Organization.
7.
Zurück zum Zitat Bunnell, R., Ekwaru, J. P., Solberg, P., Wamai, N., Bikaako-Kajura, W., Were, W., et al. (2006). Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS, 20(1), 85.PubMedCrossRef Bunnell, R., Ekwaru, J. P., Solberg, P., Wamai, N., Bikaako-Kajura, W., Were, W., et al. (2006). Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS, 20(1), 85.PubMedCrossRef
8.
Zurück zum Zitat Stangl, A. L., Wamai, N., Mermin, J., Awor, A. C., & Bunnell, R. (2007). Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda. AIDS Care, 19(5), 626–636.PubMedCrossRef Stangl, A. L., Wamai, N., Mermin, J., Awor, A. C., & Bunnell, R. (2007). Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda. AIDS Care, 19(5), 626–636.PubMedCrossRef
9.
Zurück zum Zitat Mermin, J., Were, W., Ekwaru, J. P., Moore, D., Downing, R., Behumbiize, P., et al. (2008). Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: A prospective cohort study. The Lancet, 371(9614), 752–759.CrossRef Mermin, J., Were, W., Ekwaru, J. P., Moore, D., Downing, R., Behumbiize, P., et al. (2008). Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: A prospective cohort study. The Lancet, 371(9614), 752–759.CrossRef
10.
Zurück zum Zitat Mast, T. C., Kigozi, G., Wabwire-Mangen, F., Black, R., Sewankambo, N., Serwadda, D., et al. (2004). Measuring quality of life among HIV-infected women using a culturally adapted questionnaire in Rakai district, Uganda. AIDS Care, 16(1), 81–94.PubMedCrossRef Mast, T. C., Kigozi, G., Wabwire-Mangen, F., Black, R., Sewankambo, N., Serwadda, D., et al. (2004). Measuring quality of life among HIV-infected women using a culturally adapted questionnaire in Rakai district, Uganda. AIDS Care, 16(1), 81–94.PubMedCrossRef
11.
Zurück zum Zitat WHO, & The WHO International Collaborating Group for the study of the WHO staging system. (1993). Proposed ‘World Health Organization staging system for HIV infection and disease’: preliminary testing by an international collaborative cross-sectional study. The WHO International Collaborating Group for the Study of the WHO Staging System. AIDS, 7(5), 711–718. WHO, & The WHO International Collaborating Group for the study of the WHO staging system. (1993). Proposed ‘World Health Organization staging system for HIV infection and disease’: preliminary testing by an international collaborative cross-sectional study. The WHO International Collaborating Group for the Study of the WHO Staging System. AIDS, 7(5), 711–718.
12.
Zurück zum Zitat Mor, V., Laliberte, L., Morris, J. N., & Wiemann, M. (1984). The Karnofsky performance status scale: An examination of its reliability and validity in a research setting. Cancer, 53(9), 2002–2007.PubMedCrossRef Mor, V., Laliberte, L., Morris, J. N., & Wiemann, M. (1984). The Karnofsky performance status scale: An examination of its reliability and validity in a research setting. Cancer, 53(9), 2002–2007.PubMedCrossRef
13.
Zurück zum Zitat Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989). Effect sizes for interpreting changes in health status. Medical Care, 27(3), S178.PubMedCrossRef Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989). Effect sizes for interpreting changes in health status. Medical Care, 27(3), S178.PubMedCrossRef
14.
Zurück zum Zitat Hedges, L. V., & Olkin, I. (1985). Statistical methods for meta-analysis. New York: Academic Press. Hedges, L. V., & Olkin, I. (1985). Statistical methods for meta-analysis. New York: Academic Press.
15.
Zurück zum Zitat Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillsdale: Lawrence Erlbaum Associates. Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillsdale: Lawrence Erlbaum Associates.
16.
Zurück zum Zitat Katz, J. N., Larson, M. G., Phillips, C. B., Fossel, A. H., & Liang, M. H. (1992). Comparative measurement sensitivity of short and longer health status instruments. Medical Care, 30(10), 917–925.PubMedCrossRef Katz, J. N., Larson, M. G., Phillips, C. B., Fossel, A. H., & Liang, M. H. (1992). Comparative measurement sensitivity of short and longer health status instruments. Medical Care, 30(10), 917–925.PubMedCrossRef
17.
Zurück zum Zitat Bolton, P., & Tang, A. M. (2002). An alternative approach to cross-cultural function assessment. Social Psychiatry and Psychiatric Epidemiology, 37(11), 537–543.PubMedCrossRef Bolton, P., & Tang, A. M. (2002). An alternative approach to cross-cultural function assessment. Social Psychiatry and Psychiatric Epidemiology, 37(11), 537–543.PubMedCrossRef
18.
Zurück zum Zitat Murri, R., Fantoni, M., Del Borgo, C., Visona, R., Barracco, A., Zambelli, A., et al. (2003). Determinants of health-related quality of life in HIV-infected patients. AIDS Care, 15(4), 581–590.PubMedCrossRef Murri, R., Fantoni, M., Del Borgo, C., Visona, R., Barracco, A., Zambelli, A., et al. (2003). Determinants of health-related quality of life in HIV-infected patients. AIDS Care, 15(4), 581–590.PubMedCrossRef
19.
Zurück zum Zitat Liu, C., Johnson, L., Ostrow, D., Silvestre, A., Visscher, B., & Jacobson, L. P. (2006). Predictors for lower quality of life in the HAART era among HIV-infected men. Journal of Acquired Immune Deficiency Syndromes, 42(4), 470.PubMedCrossRef Liu, C., Johnson, L., Ostrow, D., Silvestre, A., Visscher, B., & Jacobson, L. P. (2006). Predictors for lower quality of life in the HAART era among HIV-infected men. Journal of Acquired Immune Deficiency Syndromes, 42(4), 470.PubMedCrossRef
20.
Zurück zum Zitat Mannheimer, S. B., Matts, J., Telzak, E., Chesney, M., Child, C., Wu, A. W., et al. (2005). Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care, 17(1), 10–22.PubMedCrossRef Mannheimer, S. B., Matts, J., Telzak, E., Chesney, M., Child, C., Wu, A. W., et al. (2005). Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care, 17(1), 10–22.PubMedCrossRef
21.
Zurück zum Zitat Cederfjall, C., Langius-Eklof, A., Lidman, K., & Wredling, R. (2001). Gender differences in perceived health-related quality of life among patients with HIV infection. AIDS Patient Care STDs, 15(1), 31–39.PubMedCrossRef Cederfjall, C., Langius-Eklof, A., Lidman, K., & Wredling, R. (2001). Gender differences in perceived health-related quality of life among patients with HIV infection. AIDS Patient Care STDs, 15(1), 31–39.PubMedCrossRef
22.
Zurück zum Zitat Babikako, H. M., Neuhauser, D., Katamba, A., & Mupere, E. (2010). Feasibility, reliability and validity of health-related quality of life questionnaire among adult pulmonary tuberculosis patients in urban Uganda: Cross-sectional study. Health and Quality of Life Outcomes, 8, 93.PubMedCrossRef Babikako, H. M., Neuhauser, D., Katamba, A., & Mupere, E. (2010). Feasibility, reliability and validity of health-related quality of life questionnaire among adult pulmonary tuberculosis patients in urban Uganda: Cross-sectional study. Health and Quality of Life Outcomes, 8, 93.PubMedCrossRef
23.
Zurück zum Zitat Bajunirwe, F., Tisch, D. J., King, C. H., Arts, E. J., Debanne, S. M., & Sethi, A. K. (2009). Quality of life and social support among patients receiving antiretroviral therapy in Western Uganda. AIDS Care, 21(3), 271–279.PubMedCrossRef Bajunirwe, F., Tisch, D. J., King, C. H., Arts, E. J., Debanne, S. M., & Sethi, A. K. (2009). Quality of life and social support among patients receiving antiretroviral therapy in Western Uganda. AIDS Care, 21(3), 271–279.PubMedCrossRef
24.
Zurück zum Zitat Sowell, R. L., Seals, B. F., Moneyham, L., Demi, A., Cohen, L., & Brake, S. (1997). Quality of life in HIV-infected women in the south-eastern United States. AIDS Care, 9(5), 501–512.PubMedCrossRef Sowell, R. L., Seals, B. F., Moneyham, L., Demi, A., Cohen, L., & Brake, S. (1997). Quality of life in HIV-infected women in the south-eastern United States. AIDS Care, 9(5), 501–512.PubMedCrossRef
25.
Zurück zum Zitat Cohen, C., Revicki, D. A., Nabulsi, A., Sarocco, P. W., & Jiang, P. (1998). A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease. AIDS, 12(12), 1495.PubMedCrossRef Cohen, C., Revicki, D. A., Nabulsi, A., Sarocco, P. W., & Jiang, P. (1998). A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease. AIDS, 12(12), 1495.PubMedCrossRef
26.
Zurück zum Zitat Tarwater, P. M., Gallant, J. E., Mellors, J. W., Gore, M. E., Phair, J. P., Detels, R., et al. (2004). Prognostic value of plasma HIV RNA among highly active antiretroviral therapy users. AIDS, 18(18), 2419.PubMed Tarwater, P. M., Gallant, J. E., Mellors, J. W., Gore, M. E., Phair, J. P., Detels, R., et al. (2004). Prognostic value of plasma HIV RNA among highly active antiretroviral therapy users. AIDS, 18(18), 2419.PubMed
27.
Zurück zum Zitat Wu, A. W., Rubin, H. R., Mathews, W. C., Ware, J. E., Jr, Brysk, L. T., Hardy, W. D., et al. (1991). A health status questionnaire using 30 items from the Medical Outcomes Study: Preliminary validation in persons with early HIV infection. Medical Care, 29(8), 786.PubMedCrossRef Wu, A. W., Rubin, H. R., Mathews, W. C., Ware, J. E., Jr, Brysk, L. T., Hardy, W. D., et al. (1991). A health status questionnaire using 30 items from the Medical Outcomes Study: Preliminary validation in persons with early HIV infection. Medical Care, 29(8), 786.PubMedCrossRef
Metadaten
Titel
Measuring quality of life in rural Uganda: reliability and validity of summary scores from the Medical Outcomes Study HIV Health Survey (MOS-HIV)
verfasst von
Anne L. Stangl
Rebecca Bunnell
Nafuna Wamai
Humphrey Masaba
Jonathan Mermin
Publikationsdatum
01.11.2012
Verlag
Springer Netherlands
Erschienen in
Quality of Life Research / Ausgabe 9/2012
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-011-0075-5

Weitere Artikel der Ausgabe 9/2012

Quality of Life Research 9/2012 Zur Ausgabe

Premium Partner